Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisDavid Adams, Ole B. Suhr, Alejandra González‐Duarte et al.|New England Journal of Medicine|2018Cited by 2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisJulian D. Gillmore, Philip N. Hawkins, Matthew J. Maurer et al.|Circulation|2016Cited by 2k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory DisorderLaetitia Agostini, Jürg Tschopp, Fabio Martinon et al.|Immunity|2004Cited by 1.7k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisMorie A. Gertz, G Grateau, Pierre Ronco et al.|American Journal of Hematology|2005Cited by 1.4k
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesisDavid R. Booth, Mark B. Pepys, Margaret Sunde et al.|Nature|1997Cited by 1k